Sharp Therapeutics Corp. SHRX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.93M | -4.89M | -6.92M | -4.07M | -- |
| Total Depreciation and Amortization | 92.60K | 93.50K | 98.30K | 120.50K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 896.80K | -410.10K | 1.58M | -1.06M | -- |
| Change in Net Operating Assets | 560.20K | 642.80K | 423.40K | -290.60K | -- |
| Cash from Operations | -4.38M | -4.56M | -4.81M | -5.31M | -- |
| Capital Expenditure | -- | -- | -- | 0.00 | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 5.10K | -- |
| Cash from Investing | -- | -- | -- | 5.10K | -- |
| Total Debt Issued | 1.55M | 775.00K | -- | 0.00 | -- |
| Total Debt Repaid | -212.20K | -206.10K | -200.00K | -436.80K | -- |
| Issuance of Common Stock | 41.00K | 2.52M | 2.52M | 7.45M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 400.00K | -- |
| Cash from Financing | 1.38M | 3.09M | 2.32M | 7.42M | -- |
| Foreign Exchange rate Adjustments | -46.30K | -14.30K | -37.00K | 13.90K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -400.00K | -- |
| Net Change in Cash | -3.04M | -1.49M | -2.53M | 1.73M | -- |